Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae - Wikidata - wikimedia - TriplyDB

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

http://www.wikidata.org/entity/Q41870610

about

"Stormy waters ahead": global emergence of carbapenemases Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America Kinetics of avibactam inhibition against Class A, C, and D β-lactamases New β-Lactamase Inhibitors in the Clinic Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics The β-Lactams Strike Back: Ceftazidime-Avibactam Healthcare-associated infections, infection control and the potential of new antibiotics in development in the USA OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections Targeting Antibiotic Resistance Clinical management of infections caused by multidrug-resistant Enterobacteriaceae Class D β-lactamases: a reappraisal after five decades An Automated Miniaturized Method to Perform and Analyze Antimicrobial Drug Synergy Assays New β-lactamase inhibitors: a therapeutic renaissance in an MDR world.Discovery research: the scientific challenge of finding new antibiotics.Reclaiming the efficacy of β-lactam-β-lactamase inhibitor combinations: avibactam restores the susceptibility of CMY-2-producing Escherichia coli to ceftazidime.Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.Investigational antimicrobial agents of 2013.Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.Interaction of Avibactam with Class B Metallo-β-Lactamases.In vivo efficacy of humanized exposures of Ceftazidime-Avibactam in comparison with Ceftazidime against contemporary Enterobacteriaceae isolates.Unexpected in vivo activity of ceftazidime alone and in combination with avibactam against New Delhi metallo-β-lactamase-producing Enterobacteriaceae in a murine thigh infection model.Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases.Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections.Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study.Enhancing the utility of existing antibiotics by targeting bacterial behaviour?New Delhi Metallo-beta lactamase-1 containing enterobacteriaceae: origin, diagnosis, treatment and public health concern.Current epidemiology and growing resistance of gram-negative pathogens.Randomized pharmacokinetic and drug-drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases Comparative in vitro and in vivo efficacies of human simulated doses of ceftazidime and ceftazidime-avibactam against Pseudomonas aeruginosa.Characterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1.Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.Role of the Outer Membrane and Porins in Susceptibility of β-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014).

P2860

Q21131125-C12B496A-35CA-43F6-B0CD-777A029F4A83 Q21146707-FEEF6EA8-78F4-4F06-9387-07A47C6789D1 Q24601746-C7833F75-254A-47CA-BCEF-9154F554E4E4 Q24617763-F920D1A5-A941-4E86-9596-FDE8819F93FE Q26747150-F296EAFE-8604-43AD-B727-811450FF431B Q26783267-2ED2D1BD-4459-4344-A23A-6CB911D6811B Q26796425-1F8951F5-16F3-4C9D-9DF6-C0E45A08DCA6 Q26995305-03C30735-262E-49FB-8156-2258A25A3B09 Q27701037-75B6CCE4-9C74-48D5-9AC4-F3A606D400D4 Q28069563-C895A46F-6745-4DFC-A098-8379507CB2B5 Q28078130-12037017-5A22-4001-AF8F-666234562532 Q28246841-F6BF2FFE-F069-4785-A6F0-F2E75BD3ECA8 Q28295700-737F04DA-4796-4DE9-8F12-E9FEAEB41678 Q30364361-4AFFC22E-53B3-4E9E-B459-E369BF439F4A Q33622976-F4E43E32-B2D0-434C-879E-DD10C293394E Q33941796-99FE5C76-C5FD-40A2-A326-BF27E2A087B9 Q34058217-D35EEA00-7468-4E70-BABB-F6F928CF3307 Q34325573-1DCF059A-7AE9-497F-925F-53479A52A958 Q34375204-5313CE1E-755D-42BC-BDAA-DBB64904DB52 Q34447679-2A30F4DE-4A6B-46CA-9FEF-7B802458E392 Q34533834-7C70433E-AF30-4FE0-B1F1-1C378D9ABA57 Q34596516-E4C4C29C-EB56-4803-8D8F-2A97ECD7915B Q34596918-CBCAC6F4-D6F1-4F8F-8901-61FFE2F8A960 Q34932937-AA41CD8E-445C-4F8A-9229-7877216DC59B Q35106776-E8CA6E7C-0375-4769-8566-20205598B384 Q35556737-C6B7F981-B736-4498-AAE7-B9A8DBE53F0F Q35764780-69891AE5-961B-4AD6-935A-EC22424FF7BA Q35853204-D7A2FDBF-6236-4508-A756-311311375A27 Q35885377-F0280339-7595-4254-A8F4-8009F2639AE4 Q36025192-EB19AA66-2A47-4109-B453-DCCC8E273525 Q36201543-0ACB8FBF-7C13-445D-A455-8739476DF96D Q36290482-B44BF220-3C1B-4D23-A63A-DBD1104DCA7D Q36357629-E9F30F53-6108-4C57-AB33-79FB63BC72AC Q36396244-97E777F7-43D2-4ED6-A9B2-BD2B759A6E05 Q36571851-B7940D82-A92D-43A6-9A56-23CCB191ECD6 Q36571962-78D698BF-7DEB-4349-BA59-8CE09C2D3DC6 Q36644679-0983BF45-F435-4EF0-9E4F-2A210DCF905E Q36667104-6BA6D050-BF7A-4F37-9A81-3AB9069661B5 Q36887866-3B3B7DD4-A746-49B8-ABDB-89C4DEA8821C Q36888062-46412D39-2932-4108-9152-EFD46E77C391

P2860

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

http://www.wikidata.org/entity/Q41870610

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Activities of NXL104 combinati ...... e-Producing Enterobacteriaceae

@en

type

label

Activities of NXL104 combinati ...... e-Producing Enterobacteriaceae

@en

prefLabel

Activities of NXL104 combinati ...... e-Producing Enterobacteriaceae

@en

P1433

Q41870610-CBF44461-3EB7-471E-8416-299215F7664C

P1476

Q41870610-79308671-16D3-4E9F-A25E-A91518890AF9

P2093

Q41870610-01495D5A-169D-4558-A8A3-955F44456638

Q41870610-18187F46-6FA5-4D10-A254-08BAFAC0D2DB

Q41870610-4664454F-2672-47B7-9AF0-CBF5AB4729DA

Q41870610-9D5DC99A-E272-43BF-9718-DE4210AF3474

Q41870610-D9E4A462-77FA-45B1-9B93-A717BA5536D8

Q41870610-ECC9F659-C11B-47F9-8778-FFCBE65E3B88

P2860

Q41870610-114DB2D0-3EF5-4879-B38D-29EAF5A1214E

Q41870610-166CA0D3-F88F-4CC6-92EF-D719D97D465C

Q41870610-1C8B63A4-C90B-46B7-BAF6-64FED61FD3B8

Q41870610-1D19D3E9-4686-401D-8FD1-976C2C744007

Q41870610-3003363F-BC8B-4E54-8F52-8F70EC61D45A

Q41870610-3B4A8886-3FC8-468D-8D25-1B9D75A62563

Q41870610-5D5E80BC-AA19-4661-B72C-3D399631D820

Q41870610-6550CF1C-D437-46A5-BAC4-4D175D81837A

Q41870610-6A6A36E9-C8F5-4AE9-B4DD-3CE511569CBA

Q41870610-7C75F01F-744B-4741-AD0B-B46C5A54FDA7

P304

Q41870610-BC001891-1F6A-43A2-A5B2-8561CFF61DDB

P31

Q41870610-D35BEAF0-4538-411A-9214-EF14E3B2E339

P356

Q41870610-8BE6ECDD-4088-4DF2-8A2C-B711736B13B7

P407

Q41870610-65235894-6DAB-4CF0-B9E9-DE9F31E2F539

P433

Q41870610-E64E7B9B-0669-4739-A84D-09C99335B684

P478

Q41870610-68B3467C-0AC5-4B22-A6E0-56873E28BE61

P50

Q41870610-74A4D094-37BF-485E-A4E8-B18C6C26743E

P577

Q41870610-11183B8B-B8AC-477C-A75E-7B9997FFB23C

P698

Q41870610-C368C826-30E0-4CDD-802A-A31352CCEE91

P932

Q41870610-1AE27B25-8109-495E-9C7F-C19741A33961

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Activities of NXL104 combinati ...... e-Producing Enterobacteriaceae

@en

P2093

David M Livermore

http://www.w3.org/2001/XMLSchema#string

Jiancheng Zhang

http://www.w3.org/2001/XMLSchema#string

Marina Warner

http://www.w3.org/2001/XMLSchema#string

Michel Doumith

http://www.w3.org/2001/XMLSchema#string

Shazad Mushtaq

http://www.w3.org/2001/XMLSchema#string

Sunil Maharjan

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

Three decades of beta-lactamase inhibitors

Carbapenemases: the versatile beta-lactamases

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues.

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter.

Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.

High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence.

Spread of OXA-48-encoding plasmid in Turkey and beyond.

Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

P304

390-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00756-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21041502

http://www.w3.org/2001/XMLSchema#string

P932

3019623

http://www.w3.org/2001/XMLSchema#string